Controlling Health Care Costs Prospects for Drug-Pricing Reform Under a Biden–Harris Administration Blog / Mar 23, 2021
Controlling Health Care Costs Addressing Medicare Solvency Will Require Both Revenue and Spending Changes Blog / Jan 28, 2021
Controlling Health Care Costs Any Medicare Solvency Effort Must Include Advancing Health Equity Blog / Jan 28, 2021
Controlling Health Care Costs Options for Extending Medicare’s Trust Fund: The Commonwealth Fund Solvency Series Blog / Jan 28, 2021
Controlling Health Care Costs The Trump Administration’s Latest Prescription Drug Rulemaking and Options for President-elect Biden Blog / Dec 03, 2020
Controlling Health Care Costs Striking the Right Balance Between Lowering U.S. Prescription Drug Prices and Preserving Incentives for Innovation Journal Article / Dec 02, 2020
Controlling Health Care Costs Getting to Lower Prescription Drug Prices: The Key Drivers of Costs and What Policymakers Can Do to Address Them Fund Reports / Oct 01, 2020
Controlling Health Care Costs Not So Sweet: Insulin Affordability over Time Issue Briefs / Sep 25, 2020
Controlling Health Care Costs The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are Issue Briefs / Apr 09, 2020
Controlling Health Care Costs Will Medicare Prescription Drug Reform Legislation Make Insulin More Affordable? Journal Article / Apr 02, 2020
Achieving Universal Coverage Everything You Need to Know About Health Care in 2019 Podcast / Dec 20, 2019
Controlling Health Care Costs Looking Ahead: Policy Options for Addressing High Drug Prices Blog / Jul 30, 2019